4/A//SEC Filing
ENZO BIOCHEM INC 4/A
Accession 0000911420-05-000223
CIK 0000316253operating
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 9:47 PM ET
Size
7.6 KB
Accession
0000911420-05-000223
Insider Transaction Report
Form 4/AAmended
GOLDBERG DAVID C
VP, Corporate Development
Transactions
- Exercise/Conversion
Common Stock, Par Value $0.01
2005-05-26$6.84/sh+7,035$48,119→ 35,658 total - Exercise/Conversion
Incentive Stock Options
2005-05-26−7,035→ 77,373 totalExercise: $6.84From: 1999-05-31Exp: 2005-05-31→ Common Stock (7,035 underlying)
Footnotes (3)
- [F1]As of the date hereof, the Reporting Person directly beneficially owns 32,149 shares of Common Stock, 2,576 shares of Common Stock in Enzo Biochem's 401K plan, and has an indirect beneficial interest in 933 shares as custodian for certain of his children.
- [F2]The option vested in four equal annual installments, beginning on May 31, 1995.
- [F3]As of the date hereof, the Reporting Person directly beneficially owns 77,373 options to purchase Common Stock, 44,663 of which are currently exercisable.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000316253
Filing Metadata
- Form type
- 4/A
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 9:47 PM ET
- Size
- 7.6 KB